Andersons pediatric cardiology 1582

64 Venkat-Raman N, Sebire NJ, Murphy KW Recurrent fetal hydrops due to mucopolysaccharidoses type VII Fetal Diagn Ther 2006;21(3):250–254 65 Sleeper MM, Fornasari B, Ellinwood NM, et al Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII Circulation 2004;110(7):815–820 66 Leroy JG, Demars RI Mutant enzymatic and cytological phenotypes in cultured human fibroblasts Science 1967;157:804–806 67 Kudo M, Brem MS, Canfield WM Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical Pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase α/β–subunits precursor gene Am J Hum Genet 2006;78(3):451–463 68 Leroy JG, Cathey S, Friez MJ Mucolipidosis II Pagon RA, Adam MP, Ardinger HH, et al GeneReviews University of Washington: Seattle (WA); 2008 [Seattle; 1993-2017; [updated 2012 May 10] 69 Sakura N, Hayashida M, Waki C, Kobayashi M, Tanimoto T Asymmetric ventricular septal hypertrophy in I-cell disease J Inherit Metab Dis 1986;9(4):401–402 70 Daimon M, Yamagishi M Surgical treatment of marked mitral valvar deformity combnined with I-cell disease ‘mucolipidosis II’ Cardiol Young 2005;15(5):517–519 71 Krivit W Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases Springer Semin Immunopathol 2004;26(1–2):119–132 72 Tylki-Szymanska A, Czartoryska B, Groener J, Lugowska A 2002 clinical variability in mucolipidosis III (pseudo-hurler polydystrophy) Am J Med Genet 2002;108(3):214–218 73 Leroy JG, Cathey SS, Friez MJ Mucolipidosis III Alpha/Beta Pagon RA, Adam MP, Ardinger HH, et al GeneReviews® [Internet] University of Washington,: Seattle (WA); 2008 [Seattle; 1993-2017; [updated 2012 May 10] 74 Raas-Rothschild A, Spiegel R Mucolipidosis III gamma Pagon RA, Adam MP, Ardinger HH, et al GeneReviews University of Washington: Seattle (WA); 2010 [Seattle; 1993-2017; [updated 2012 Jul 5] 75 Mehta J, Desnick RJ Abbreviated PR interval in mannosidosis J Pediatr 1978;92:599–601 76 Sun H, Wolfe JH Recent progress in lysosomal alpha-mannosidase and its deficiency Exp Mol Med 2001;33(1):1–7 77 Michalski JC, Klein A Glycoprotein lysosomal storage disorders: alpha and beta mannosidosis, fucosidosis, and alpha-nacetylgalactosaminidase deficiency Biochim Biophys Acta 1999;1455(2–3):69–84 78 Fletcher JL, Taylor RM Therapy development for the lysosomal storage disease fucosidosis using the canine animal model Pediatr Endocrinol Rev 2016;13(suppl 1):697–706 79 Kelly TE, Bartoshesky L, Harris DJ, et al Mucolipidosis I (acid neuraminidase deficiency) Three cases and delineation of the variability of phenotype Am J Dis Child 1981;135:703–708 80 Gillan JE, Lowden JA, Gaskin K, Cutz E Congenital ascites as a presenting sign of lysosomal storage disease J Pediatr 1984;104(2):225–231 81 Oheda Y, Kotani M, Murata M, et al Elimination of abnormal sialoglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement Glycobiology 2006;16(4):271–280 82 Tatano Y, Takeuchi N, Kuwahara J, et al Elastogenesis in cultured dermal fibroblasts from patients with lysosomal β-galactosidase, protective prtoein/cathepsin A and neuraminidase-1 deficiencies J Med Invest